Premium
Risk of death from methicillin‐resistant Staphylococcus aureus bacteraemia: a meta‐analysis
Author(s) -
Whitby Michael,
McLaws MaryLouise,
Berry Geoffrey
Publication year - 2001
Publication title -
medical journal of australia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.904
H-Index - 131
eISSN - 1326-5377
pISSN - 0025-729X
DOI - 10.5694/j.1326-5377.2001.tb143562.x
Subject(s) - medicine , staphylococcus aureus , methicillin resistant staphylococcus aureus , meta analysis , bacteremia , relative risk , cochrane library , staphylococcal infections , cause of death , confidence interval , microbiology and biotechnology , antibiotics , bacteria , disease , biology , genetics
Objective To estimate the risk of death from healthcare‐associated (nosocomial) bacteraemia caused by methicillin‐resistant Staphylococcus aureus (MRSA), and compare it with that of nosocomial bacteraemia caused by methicillin‐sensitive S. aureus (MSSA), by meta‐analysis of selected studies. Data sources Medline, EMBASE, Current Contents and Cochrane Library were searched for the period January 1978 (or earliest date of the database, if later than 1978) to December 2000. Study selection Studies which compared mortality of nosocomial MRSA and MSSA bacteraemia. Data synthesis Nine studies were analysed. All but one found an increased relative risk (RR) of death from MRSA bacteraemia, with RR ranging from 0.89 to 4.94. Meta‐analysis showed that patients with MRSA bacteraemia have an RR of death, compared with patients with MSSA bacteraemia, of 2.12 (95% CI, 1.76–2.57) using the fixed‐effect method, and 2.03 (95% CI, 1.55–2.65) using the random‐effect method. Conclusion MRSA bacteraemia is associated with a real increase in risk of death, further justifying ongoing MRSA surveillance and control in healthcare facilities.